Skip to content

Comparison of Somofilcon A Daily Disposable Test Contact Lens and Somofilcon A Daily Disposable Control Contact Lens

Comparison of Daily Disposable Invigor I (Test) and Select 1 Day Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03372551
Enrollment
36
Registered
2017-12-13
Start date
2017-11-29
Completion date
2018-04-23
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study is to investigate the overall clinical performance of the somofilcon A daily disposable test soft contact lens compared to the somofilcon A daily disposable control soft contact lens.

Detailed description

The purpose of this study is to evaluate the clinical performance of an investigational silicone-hydrogel contact lens (test) against a marketed silicone-hydrogel contact lens (control) when worn on a daily disposable wear modality over 1 week (for each lens) in a randomized, bilateral, cross-over, dispensing study.

Interventions

DEVICEsomofilcon A 1 day test lens

Contact lens

DEVICEsomofilcon A 1 day control lens

Contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Both the participants and study investigators will be masked to the randomization schedule of the contact lenses used.

Intervention model description

This will be a, prospective, double-masked, randomized, bilateral, 1 week cross-over, dispensing study

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Is at least 17 years of age and has full legal capacity to volunteer; * Has had a self-reported oculo-visual examination in the last two years; * Has read, understood, and signed the information consent letter; * Is willing and able to follow instructions and maintain the appointment schedule; * Has a visual acuity of 20/30 or better (in each eye) with their habitual vision correction, or 20/20 best-corrected vision (for binocular distance acuity); * Must be able to achieve 20/30 or better (in each eye) with the study lenses; * Currently wears soft contact lenses for at least 3 days per week, 8 hours each day; * Requires spectacle lens powers between -0.75 and -06.50 diopters sphere (0.25D steps); * Has no more than 0.75 diopters of refractive astigmatism; * Has clear corneas and no active\* ocular disease; * Has not worn lenses for at least 12 hours before the examination.

Exclusion criteria

* Is presently participating in any other clinical or research study including eye related clinical or research study; * Has never worn contact lenses before. * Has any systemic disease affecting ocular health. * Has any active\* ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses. * Is using any systemic or topical medications that will affect a study outcome variable, and/or ocular health. * Has any known sensitivity to fluorescein dye or products to be used in the study. * Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye. * Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars. * Is aphakic. * Has undergone corneal refractive surgery. * Is pregnant, lactating, or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit).

Design outcomes

Primary

MeasureTime frameDescription
Comfortup to 1 weekSubjective comfort scored 0-100 (0=Cannot be worn, 100=Cannot be felt ever)
Preferenceup to 1 weekOverall lens that subject prefers or no preference
VisionUp to 1 weekVisual acuity measured in logMAR
Subjective Visionup to 1 weekSubjective vision scored 0-100 (0=Extremely poor, 100=Excellent vision all the time)
Corneal Stainingup to 1 weekAmount of staining observed on the cornea scored 0-4 (0=none, 4=severe) in 0.25 steps
Conjunctival Stainingup to 1 weekAmount of staining observed on the conjunctiva scored 0-4 (0=none, 4=severe) in 0.25 steps

Countries

Canada

Participant flow

Pre-assignment details

Three (3) subjects did not meet inclusion criteria and were excluded from the analysis. One subject was enrolled and later discontinued.

Participants by arm

ArmCount
Somofilcon A 1 Day Test vs Control Contact Lens
Each subjects randomized to wear either the test or control as a matched pair and cross over to second matched pair. somofilcon A 1 day test lens: Test / Contact lens somofilcon A 1 day control lens: Test / Contact lens
32
Total32

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (1 Week)Withdrawal by Subject10

Baseline characteristics

CharacteristicSomofilcon A 1 Day Test vs Control Contact Lens
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
Age, Continuous26 years
STANDARD_DEVIATION 9
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
32 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
Canada
32 participants
Sex: Female, Male
Female
29 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
0 / 320 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Comfort

Subjective comfort scored 0-100 (0=Cannot be worn, 100=Cannot be felt ever)

Time frame: up to 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon A 1 Day Test LensComfortComfort at Insertion after 1 week86 score on a scaleStandard Deviation 11
Somofilcon A 1 Day Test LensComfortComfort end day after 1 week75 score on a scaleStandard Deviation 15
Somofilcon A 1 Day Test LensComfortComfort during day after 1 week84 score on a scaleStandard Deviation 11
Somofilcon A 1 Day Test LensComfortOverall comfort after 1 week of lens wear82 score on a scaleStandard Deviation 11
Somofilcon A 1 Day Test LensComfortComfort at Dispense90 score on a scaleStandard Deviation 8
Somofilcon A 1 Day Control LensComfortOverall comfort after 1 week of lens wear85 score on a scaleStandard Deviation 12
Somofilcon A 1 Day Control LensComfortComfort at Dispense89 score on a scaleStandard Deviation 11
Somofilcon A 1 Day Control LensComfortComfort at Insertion after 1 week87 score on a scaleStandard Deviation 16
Somofilcon A 1 Day Control LensComfortComfort during day after 1 week86 score on a scaleStandard Deviation 11
Somofilcon A 1 Day Control LensComfortComfort end day after 1 week78 score on a scaleStandard Deviation 16
Primary

Conjunctival Staining

Amount of staining observed on the conjunctiva scored 0-4 (0=none, 4=severe) in 0.25 steps

Time frame: up to 1 week

Population: Baseline n=32 participants / 64 eyes, 1 week n= 31 participants / 62 eyes due to non-serious adverse event participant's measurements weren't completed.

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon A 1 Day Test LensConjunctival Staining1 week0.72 score on a scaleStandard Deviation 0.57
Somofilcon A 1 Day Test LensConjunctival StainingBaseline0.20 score on a scaleStandard Deviation 0.25
Somofilcon A 1 Day Control LensConjunctival Staining1 week0.91 score on a scaleStandard Deviation 0.71
Somofilcon A 1 Day Control LensConjunctival StainingBaseline0.20 score on a scaleStandard Deviation 0.25
Primary

Corneal Staining

Amount of staining observed on the cornea scored 0-4 (0=none, 4=severe) in 0.25 steps

Time frame: up to 1 week

Population: Baseline n=32 participants / 64 eyes, 1 week n = 31 participants / 62 eyes due to non-serious adverse event participant's measurements weren't completed.

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon A 1 Day Test LensCorneal StainingBaseline0.16 score on a scaleStandard Deviation 0.25
Somofilcon A 1 Day Test LensCorneal Staining1 week0.20 score on a scaleStandard Deviation 0.26
Somofilcon A 1 Day Control LensCorneal StainingBaseline0.16 score on a scaleStandard Deviation 0.25
Somofilcon A 1 Day Control LensCorneal Staining1 week0.18 score on a scaleStandard Deviation 0.42
Primary

Preference

Overall lens that subject prefers or no preference

Time frame: up to 1 week

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Somofilcon A 1 Day Test LensPreferenceStrongly preferred somofilcon A 1 Day Test lens5 Participants
Somofilcon A 1 Day Test LensPreferenceSlightly preferred somofilcon A 1 Day Test lens9 Participants
Somofilcon A 1 Day Test LensPreferenceStrongly preferred somofilcon A 1 Day control lens12 Participants
Somofilcon A 1 Day Test LensPreferenceNo preference1 Participants
Somofilcon A 1 Day Test LensPreferenceSlightly preferred somofilcon A 1 Day Control lens5 Participants
Primary

Subjective Vision

Subjective vision scored 0-100 (0=Extremely poor, 100=Excellent vision all the time)

Time frame: up to 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon A 1 Day Test LensSubjective Vision1 week88 score on a scaleStandard Deviation 12
Somofilcon A 1 Day Test LensSubjective VisionDispense92 score on a scaleStandard Deviation 9
Somofilcon A 1 Day Control LensSubjective VisionDispense92 score on a scaleStandard Deviation 6
Somofilcon A 1 Day Control LensSubjective Vision1 week91 score on a scaleStandard Deviation 11
Primary

Vision

Visual acuity measured in logMAR

Time frame: Up to 1 week

Population: Dispensing - n=32 participants total, 1 week = 31 participants total due to a nonserious adverse events for somofilcon A 1 day test lens.

ArmMeasureGroupValue (MEAN)Dispersion
Somofilcon A 1 Day Test LensVisionHigh Illumination high contrast monocular-0.10 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Test LensVisionHigh Illumination high contrast binocular-0.15 Log(MAR)Standard Deviation 0.06
Somofilcon A 1 Day Test LensVisionLow Illumination high contrast monocular-0.08 Log(MAR)Standard Deviation 0.05
Somofilcon A 1 Day Test LensVisionLow Illumination high contrast binocular-0.13 Log(MAR)Standard Deviation 0.06
Somofilcon A 1 Day Control LensVisionHigh Illumination high contrast binocular-0.15 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Control LensVisionLow Illumination high contrast monocular-0.07 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Control LensVisionLow Illumination high contrast binocular-0.13 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Control LensVisionHigh Illumination high contrast monocular-0.10 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Control Lens DispenseVisionLow Illumination high contrast monocular-0.09 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Control Lens DispenseVisionHigh Illumination high contrast binocular-0.15 Log(MAR)Standard Deviation 0.06
Somofilcon A 1 Day Control Lens DispenseVisionLow Illumination high contrast binocular-0.13 Log(MAR)Standard Deviation 0.06
Somofilcon A 1 Day Control Lens DispenseVisionHigh Illumination high contrast monocular-0.11 Log(MAR)Standard Deviation 0.07
Somofilcon A 1 Day Control Lens 1 WeekVisionLow Illumination high contrast binocular-0.14 Log(MAR)Standard Deviation 0.05
Somofilcon A 1 Day Control Lens 1 WeekVisionHigh Illumination high contrast binocular-0.16 Log(MAR)Standard Deviation 0.06
Somofilcon A 1 Day Control Lens 1 WeekVisionHigh Illumination high contrast monocular-0.11 Log(MAR)Standard Deviation 0.06
Somofilcon A 1 Day Control Lens 1 WeekVisionLow Illumination high contrast monocular-0.10 Log(MAR)Standard Deviation 0.06

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026